Consequences of immunopathology for pathogen virulence evolution and public health: Malaria as a case study

Evolutionary Applications

Volumn 4, Issue 2, 2011, Pages 278-291

  Long, Gráinne H ^a   Graham, Andrea L ^b,c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

Anti disease intervention; Evolution; Gametocyte; Immune mediated pathology; Infectious disease; Inflammation; Pro inflammatory; Transmission; Virulence

Indexed keywords

EID: 79951618419     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/j.1752-4571.2010.00178.x     Document Type: Article

References (94)

1. Akanmori, B. D., J. A. Kurtzhals, B. Q. Goka, V. Adabayeri, M. F. Ofori, F. K. Nkrumah, C. Behr et al. 2000. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. European Cytokine Network 11:113-118.
2. Alizon, S., and M. van Baalen 2005. Emergence of a convex trade-off between transmission and virulence. The American Naturalist 165:6.
3. Alizon, S., and M. van Baalen 2008. Acute or chronic? Within-host models with immune dynamics, infection outcome, and parasite evolution. The American Naturalist 172:E244-E256
4. Alizon, S., A. Hurford, N. Mideo, and M. Van Baalen 2009. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. Journal of Evolutionary Biology 22:245-259. (JEB1658 [pii]).
5. Amante, F. H., A. Haque, A. C. Stanley, F. D. Rivera, L. M. Randall, Y. A. Wilson, G. Yeo et al. 2010. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. Journal of Immunology 185:3632-3642. (jimmunol.1000944 [pii]).
6. Anderson, R. M., and R. M. May 1982. Coevolution of hosts and parasites. Parasitology 85(Pt 2):411-426.
7. Antia, R., and M. Lipsitch 1997. Mathematical models of parasite responses to host immune defences. Parasitology 115(Suppl):S155-S167.
8. Antia, R., B. R. Levin, and R. M. May 1994. Within-host population dynamics and the evolution and maintenance of microparasite virulence. The American Naturalist 144:457-472.
9. Bell, A. S., J. C. de Roode, D. Sim, and A. F. Read 2006. Within-host competition in genetically diverse malaria infections: parasite virulence and competitive success. Evolution; International Journal of Organic Evolution 60:1358-1371.
10. Brown, S. P., L. Le Chat, and F. Taddei 2008. Evolution of virulence: triggering host inflammation allows invading pathogens to exclude competitors. Ecological Letters 11:44-51. (ELE1125 [pii]).
11. Buckling, A., and A. F. Read 2001. The effect of partial host immunity on the transmission of malaria parasites. Proceedings of the Royal Society of London Series B-Biological Sciences 268:2325-2330.
12. Carter, R., and L. H. Miller 1979. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bulletin of the World Health Organization 57(Suppl 1):37-52.
13. Carter, R., and D. Walliker 1975. New observations on the malaria parasites of rodents of the Central African Republic -Plasmodium vinckei petteri subsp. nov. and Plasmodium chabaudi Landau, 1965. Annals of Tropical Medicine and Parasitology 69:187-196.
14. Chang, K. H., and M. M. Stevenson 2004. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. International Journal for Parasitology 34:1501-1516.
15. Clark, I. A., L. M. Alleva, A. C. Mills, and W. B. Cowden 2004. Pathogenesis of malaria and clinically similar conditions. Clinical Microbiology Reviews 17:509-539.
16. Clark, I. A., A. C. Budd, L. M. Alleva, and W. B. Cowden 2006. Human malarial disease: a consequence of inflammatory cytokine release. Malaria Journal 5:85. (1475-2875-5-85 [pii]).
17. Corrigan, R. A., and J. A. Rowe 2010. Strain variation in early innate cytokine induction by Plasmodium falciparum. Parasite Immunology 32:512-527.
18. Day, T., A. L. Graham, and A. F. Read 2007. Evolution of parasite virulence when host responses cause disease. Proceedings of the Royal Society of London Series B-Biological Sciences 274:2685-2692.
19. Dodoo, D., F. M. Omer, J. Todd, B. D. Akanmori, K. A. Koram, and E. M. Riley 2002. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. Journal of Infectious Disease 185:971-979.
20. Dyer, M., and K. P. Day 2000. Commitment to gametocytogenesis in Plasmodium falciparum. Parasitology Today 16:102-107.
21. Ebert, D., and J. J. Bull 2003. Challenging the trade-off model for the evolution of virulence: is virulence management feasible? Trends in Microbiology 11:15-20.
22. Ebert, D., and E. A. Herre 1996. The evolution of parasitic diseases. Parasitol Today 12:96-101.
23. Ewald, P. W. 1983. Host-parasite relations, vectors and the evolution of disease severity. Annual Review of Ecology and Systematics 14:465-485.
24. Fenner, F., and R. N. Ratcliffe 1965 Myxomatosis. Cambridge University Press.
25. Ferguson, H. M., M. J. Mackinnon, B. H. Chan, and A. F. Read 2003. Mosquito mortality and the evolution of malaria virulence. Evolution; International Journal of Organic Evolution 57:2792-2804.
26. Florquin, S., Z. Amraoui, D. Abramowicz, and M. Goldman 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. Journal of Immunology 153:2618-2623.
27. Frank, S. A. 1996. Models of parasite virulence. Quarterly Review of Biology 71:37-78.
28. Frank, S. A., and P. Schmid-Hempel 2008. Mechanisms of pathogenesis and the evolution of parasite virulence. Journal of Evolutionary Biology 21:396-404. (JEB1480 [pii]).
29. Fraser, C., T. D. Hollingsworth, R. Chapman, F. de Wolf, and W. P. Hanage 2007. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proceedings of the National Academy of Sciences of the United States of America 104:17441-17446. (0708559104 [pii]).
30. Gandon, S., M. J. Mackinnon, S. Nee, and A. F. Read 2001. Imperfect vaccines and the evolution of pathogen virulence. Nature 414:751-756.
31. Gazzinelli, R. T., M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R. Kuhn, W. Muller et al. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Journal of Immunology 157:798-805.
32. Germain, R. N. 2001. The art of the probable: system control in the adaptive immune system. Science 293:240-245.
33. Graham, A. L., J. E. Allen, and A. F. Read 2005a. Evolutionary causes and consequences of immunopathology. Annual Review of Ecology, Evolution, & Systematics 36:337-397.
34. Graham, A. L., T. J. Lamb, A. F. Read, and J. E. Allen 2005b. Malaria-filaria coinfection in mice makes malarial disease more severe unless filarial infection achieves patency. Journal of Infectious Diseases 191:410-421.
35. Grau, G. E., T. E. Taylor, M. E. Molyneux, J. J. Wirima, P. Vassalli, M. Hommel, and P. H. Lambert 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. New England Journal of Medicine 320:1586-1591.
36. Grech, K., B. H. Chan, R. F. Anders, and A. F. Read 2008. The impact of immunization on competition within Plasmodium infections. Evolution 62:2359-2371. (EVO438 [pii]).
37. Haydon, D. T., L. Matthews, R. Timms, and N. Colegrave 2003. Top-down or bottom-up regulation of intra-host blood-stage malaria: do malaria parasites most resemble the dynamics of prey or predator? Proceedings of the Royal Society of London Series B-Biological Sciences 270:289-298.
38. van Hensbroek, M. B., A. Palmer, E. Onyiorah, G. Schneider, S. Jaffar, G. Dolan, H. Memming et al. 1996. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. Journal of Infectious Diseases 174:1091-1097.
39. Holscher, C., M. Mohrs, W. J. Dai, G. Kohler, B. Ryffel, G. A. Schaub, H. Mossmann et al. 2000. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infection and Immunity 68:4075-4083.
40. Huijben, S., W. A. Nelson, A. R. Wargo, D. G. Sim, D. R. Drew, and A. F. Read 2010. Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites. Evolution 64:2952-2968. (EVO1068 [pii]).
41. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick et al. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. Journal of Immunology 158:3311-3316.
42. Jakel, T., M. Scharpfenecker, P. Jitrawang, J. Ruckle, D. Kliemt, U. Mackenstedt, S. Hongnark et al. 2001. Reduction of transmission stages concomitant with increased host immune responses to hypervirulent Sarcocystis singaporensis, and natural selection for intermediate virulence. International Journal for Parasitology 31:1639-1647.
43. de Jong, M. D., C. P. Simmons, T. T. Thanh, V. M. Hien, G. J. Smith, T. N. Chau, D. M. Hoang et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Medicine 12:1203-1207.
44. Karunaweera, N. D., R. Carter, G. E. Grau, D. Kwiatkowski, G. Del Giudice, and K. N. Mendis 1992. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clinical and Experimental Immunology 88:499-505.
45. Kebaier, C., H. Louzir, M. Chenik, A. Ben Salah, and K. Dellagi 2001. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response. Infection and Immunity 69:4906-4915.
46. Kullberg, M. C., J. M. Ward, P. L. Gorelick, P. Caspar, S. Hieny, A. Cheever, D. Jankovic et al. 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infection and Immunity 66:5157-5166.
47. Kwiatkowski, D. 1990. Tumour necrosis factor, fever and fatality in falciparum malaria. Immunology Letters 25:213-216.
48. Kwiatkowski, D., M. E. Molyneux, S. Stephens, N. Curtis, N. Klein, P. Pointaire, M. Smit et al. 1993. Anti-TNF therapy inhibits fever in cerebral malaria. The Quarterly Journal of Medicine 86:91-98.
49. Levin, B. R., and J. J. Bull 1994. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends in Microbiology 2:76-81.
50. Li, C., E. Seixas, and J. Langhorne 2001. Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite. Med Microbiol Immunol (Berl) 189:115-126.
51. Lipsitch, M., and E. R. Moxon 1997. Virulence and transmissibility of pathogens: what is the relationship? Trends in Microbiology 5:31-37.
52. Little, T. J., D. M. Shuker, N. Colegrave, T. Day, and A. L. Graham 2010. The coevolution of virulence: tolerance in perspective. PLoS Pathogens 6
53. Long, G. H., B. H. Chan, J. E. Allen, A. F. Read, and A. L. Graham 2006. Parasite genetic diversity does not influence TNF-mediated effects on the virulence of primary rodent malaria infections. Parasitology 133:673-684.
54. Long, G. H., B. H. Chan, J. E. Allen, A. F. Read, and A. L. Graham 2008a. Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites. BMC Evolutionary Biology 8:128. (1471-2148-8-128 [pii]).
55. Long, G. H., B. H. Chan, J. E. Allen, A. F. Read, and A. L. Graham 2008b. Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection. International Journal for Parasitology 38:1073-1081. (S0020-7519(07)00474-2 [pii]).
56. Long, G. H., A. T. Karanikas, E. T. Harvill, A. F. Read, and P. J. Hudson 2010. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proceedings. Biological Sciences 277:2017-2025. rspb.2010.0010 [pii]).
57. Looareesuwan, S., L. Sjostrom, S. Krudsood, P. Wilairatana, R. S. Porter, F. Hills, and D. A. Warrell 1999. Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria. American Journal of Tropical Medicine and Hygiene 61:26-33.
58. Mackinnon, M. J., and K. Marsh 2010. The selection landscape of malaria parasites. Science 328:866-871. (328/5980/866 [pii]).
59. Mackinnon, M. J., and A. F. Read 1999a. Genetic relationships between parasite virulence and transmission in the rodent malaria Plasmodium chabaudi. Evolution. International Journal of Organic Evolution 53:689-703.
60. Mackinnon, M. J., and A. F. Read 1999b. Selection for high and low virulence in the malaria parasite Plasmodium chabaudi. Proceedings of the Royal Society of London Series B-Biological Sciences 266:741-748.
61. Mackinnon, M. J., and A. F. Read 2003. The effects of host immunity on virulence-transmissibility relationships in the rodent malaria parasite Plasmodium chabaudi. Parasitology 126:103-112.
62. Mackinnon, M. J., and A. F. Read 2004a. Virulence in malaria: an evolutionary viewpoint. Philosophical Transactions of the Royal Society B: Biological Sciences 359:965-986.
63. Mackinnon, M. J., and A. F. Read 2004b. Immunity promotes virulence evolution in a malaria model. PLoS Biology 2:1286-1292.
64. Mackinnon, M. J., D. J. Gaffney, and A. F. Read 2002. Virulence in rodent malaria: host genotype by parasite genotype interactions. Infection, Genetics and Evolution 1:287-296.
65. Mackinnon, M. J., S. Gandon, and A. F. Read 2008. Virulence evolution in response to vaccination: the case of malaria. Vaccine 26(Suppl 3):C42-C52.
66. Magalon, H., T. Nidelet, G. Martin, and O. Kaltz 2010. Host growth conditions influence experimental evolution of life history and virulence of a parasite with vertical and horizontal transmission. Evolution 64:2126-2138. (PMID: 20163449).
67. Margolis, E., and B. R. Levin 2008. The evolution of bacteria-host interactions: virulence and the immune over-response. In J-A. Gutteriez, and F. M. Baquero, eds. Introduction to the Evolutionary Biology of Bacterial and Fungal Pathogens. ASM Press, Washington, DC.
68. Masumu, J., T. Marcotty, N. Ndeledje, C. Kubi, S. Geerts, J. Vercruysse, P. Dorny et al. 2006. Comparison of the transmissibility of Trypanosoma congolense strains, isolated in a trypanosomiasis endemic area of eastern Zambia, by Glossina morsitans morsitans. Parasitology 133:331-334.
69. Medica, D. L., and M. V. Sukhdeo 2001. Estimating transmission potential in gastrointestinal nematodes (order: Strongylida). Journal of Parasitology 87:442-445.
70. Meunier, P. C., B. J. Cooper, M. J. Appel, and D. O. Slauson 1985. Pathogenesis of canine parvovirus enteritis: the importance of viremia. Veterinary pathology 22:60-71.
71. Mideo, N. 2009. Parasite adaptations to within-host competition. Trends Parasitol 25:261-268. (S1471-4922(09)00081-6 [pii]).
72. Mordue, D. G., F. Monroy, M. La Regina, C. A. Dinarello, and L. D. Sibley 2001. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. Journal of Immunology 167:4574-4584.
73. Naotunne, T. S., N. D. Karunaweera, G. Del Giudice, M. U. Kularatne, G. E. Grau, R. Carter, and K. N. Mendis 1991. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. The Journal of Experimental Medicine 173:523-529.
74. Naotunne, T. S., N. D. Karunaweera, K. N. Mendis, and R. Carter 1993. Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 78:555-562.
75. Paul, R. E., T. Lafond, C. D. Muller-Graf, S. Nithiuthai, P. T. Brey, and J. C. Koella 2004. Experimental evaluation of the relationship between lethal or non-lethal virulence and transmission success in malaria parasite infections. BMC Evolutionary Biology 4:30. (1471-2148-4-30 pii).
76. Raberg, L., A. L. Graham, and A. F. Read 2009. Decomposing health: tolerance and resistance to parasites in animals. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 364:37-49. (Y0N0801283423547 [pii]).
77. Read, A. F. 1994. The evolution of virulence. Trends in Microbiology 2:73-76.
78. Read, A. F., and M. J. Mackinnon 2008. Pathogen evolution in a vaccinated world. In S. C. Stearns, and J. Koella, eds. Evolution in Health and Disease 2, pp. 139-152. Oxford University Press, Oxford, UK.
79. Ritter, K., A. Kuhlencord, R. Thomssen, and W. Bommer 1993. Prolonged haemolytic anaemia in malaria and autoantibodies against triosephosphate isomerase. Lancet 342:1333-1334. (0140-6736(93)92248-R [pii]).
80. Romagnani, S. 1996. Understanding the role of Th1/Th2 cells in infection. Trends in Microbiology 4:470-473. (S0966842X9782906X [pii]).
81. de Roode, J. C., A. J. Yates, and S. Altizer 2008. Virulence-transmission trade-offs and population divergence in virulence in a naturally occurring butterfly parasite. Proceedings of the National Academy of Sciences of the United States of America 105:7489-7494. (0710909105 [pii]).
82. Safeukui, I., J. M. Correas, V. Brousse, D. Hirt, G. Deplaine, S. Mule, M. Lesurtel et al. 2008. Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood 112:2520-2528. (blood-2008-03-146779 [pii]).
83. Schofield, L., and G. E. Grau 2005. Immunological processes in malaria pathogenesis. Nature Reviews Immunology 5:722-735.
84. Schofield, L., M. C. Hewitt, K. Evans, M. A. Siomos, and P. H. Seeberger 2002. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418:785-789.
85. Serghides, L., T. G. Smith, S. N. Patel, and K. C. Kain 2003. CD36 and malaria: friends or foes? Trends Parasitol 19:461-469. (S1471492203002204 [pii]).
86. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
87. Stevenson, M. M., and E. M. Riley 2004. Innate immunity to malaria. Nature Reviews Immunology 4:169-180.
88. Stevenson, M. M., J. J. Lyanga, and E. Skamene 1982. Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infection and Immunity 38:80-88.
89. Taylor, L. H., and A. F. Read 1997. Why so few transmission stages? Reproductive restraint by malaria parasites. Parasitol Today 13:135-140.
90. Timms, R., N. Colegrave, B. H. Chan, and A. F. Read 2001. The effect of parasite dose on disease severity in the rodent malaria Plasmodium chabaudi. Parasitology 123:1-11.
91. Waitumbi, J. N., M. O. Opollo, R. O. Muga, A. O. Misore, and J. A. Stoute 2000. Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood 95:1481-1486.
92. Wargo, A. R., S. Huijben, J. C. de Roode, J. Shepherd, and A. F. Read 2007. Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proceedings of the National Academy of Sciences of the United States of America 104:19914-19919. (0707766104 [pii]).
93. Wickramasinghe, S. N., and S. H. Abdalla 2000. Blood and bone marrow changes in malaria. Baillieres Best Practice and Research. Clinical Haematology 13:277-299.
94. Williams, P. D. 2009. Darwinian interventions: taming pathogens through evolutionary ecology. Trends Parasitol 26:83-92. (S1471-4922(09)00260-8 [pii]).